A recent study revealed decreased XPO4 hepatic expression with advancement of liver fibrosis through regulation of transforming growth factor beta (TGF-β)/SMAD3/SMAD4 -mediated HSC activation [7]. This evidence concerns the gene SMAD3 and Hepatic fibrosis.